Firefly Neuroscience (AIFF) Other Operating Expenses (2021 - 2026)

Firefly Neuroscience's Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 84.66% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$26.6 million (up 7.02% YoY), while the FY2025 annual figure was -$20.1 million, down 87.02% from the prior year.
• Other Operating Expenses was -$2.0 million for Q1 2026 at Firefly Neuroscience, up from -$20.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.4 million in Q2 2023 to a low of -$20.1 million in Q4 2025.
• Historically, Other Operating Expenses has averaged -$4.6 million across 5 years, with a median of -$2.1 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses surged 121.27% in 2023, then slumped 203574.06% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at -$4.7 million in 2022, then soared by 121.27% to $1.0 million in 2023, then sank by 1175.2% to -$10.8 million in 2024, then slumped by 87.02% to -$20.1 million in 2025, then soared by 90.03% to -$2.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.0 million (Q1 2026), -$20.1 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.